CAS: 7295-76-3; 3-Methoxypyridine

该化合物是一种环环环有机化合物,其3点位置上用甲氧基组替代了一条环状腺环,黄色液体明显可见,在普通有机溶剂中溶解,呈现出中度极化,成为制药和农用化学合成的多功能中间体.其电子富含丙烯酮核心和甲基代谢可增强核生殖和电药替代反应的回性.该化合物因其在制造复合分子(包括活性药物成分和催化解用离心)方面的作用而特别受到重视. 其沸点大约为175-177°C和在适当贮存下稳定的储存期寿命,它提供了合成应用的可靠性能.

结构式图片

相似化合物

109345-94-0 18677-48-0 88111-63-1

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号14906-61-7 3-甲氧基嘧啶-1-氧 | CAS号626-55-1 3-溴吡啶 | CAS号67-56-1 甲醇 | CAS号50720-12-2 3-溴-5-甲氧基吡啶 | CAS号124-41-4 甲醇钠 | CAS号626-60-8 3-氯吡啶 | CAS号109-00-2 3-羟基吡啶 | CAS号74-88-4 碘甲烷 | CAS号186581-53-3 重氮甲烷 | CAS号104642-51-5 1-(2,4-dinitrop... | CAS号4045-29-8 3-甲氧基哌啶 | CAS号19355-04-5 3-甲氧基-4-硝基吡啶 1-氧化物 | CAS号93560-55-5 2-碘-3-甲氧基吡啶 | CAS号52334-90-4 4-氨基-3-甲氧基吡啶 | CAS号113118-83-5 5-甲氧基-3-吡啶甲醛 | CAS号10201-71-5 2-氨基-3-甲氧基吡啶 | CAS号109-00-2 3-羟基吡啶 | CAS号14906-61-7 3-甲氧基嘧啶-1-氧 | CAS号20265-37-6 2-硝基-3-甲氧基吡啶

合成工艺路线路线简述

    3-氟吡啶置于iron(Iii) Chloride,双氧水,甲烷,一水合肼,溶剂黄146,Sodium Iodide体系中,用 甲醇,乙醇,水 作为反应溶剂,化学反应 20.0H,反应生成 3-甲氧基吡啶
    参考文献:一种杂环化合物3-甲氧基吡啶的合成方法
    标题:一种杂环化合物3-甲氧基吡啶的合成方法
    摘要:本发明公开一种杂环化合物3‑甲氧基吡啶的合成方法,包括如下步骤:将原料3‑卤代吡啶,双氧水,乙酸放入三口烧瓶中,在搅拌条件下40~80oc反应4~8H,回收乙酸,加入饱和的碳酸钠溶液搅拌,使体系呈碱性,蒸去水后,加入氯仿洗涤,真空蒸馏得到n‑氧化‑3‑卤代吡啶;将3‑卤吡啶‑n‑的氧化物,烷基醇的金属盐,催化剂a及醇分别加入三口烧瓶中,在搅拌的条件下回流反应5‑8H后,冷却,中和至中性,精馏得到n‑氧化‑3‑烷氧基吡啶;将n‑氧化‑3‑烷氧基吡啶,三氯化铁,水合肼,活性炭和乙醇分别加入三口烧瓶中,70oc反应3H,冷却至室温,真空蒸馏得到3‑甲氧基吡啶.本发明中间体转化率高,反应条件温和,操作安全,原料价廉易得,适合工业化生产.

    海关参考信息

    专利信息


    专利号:US-7160517-B2
    优先权日:2000-08-18
    标题 :Apparatus and methods for the automated synthesis of oligosaccharides
    发明人:SEEBERGER PETER H; PLANTE OBADIAH J
    权利人:MASSACHUSETTS INST OF TECHNOLG
    摘要:One aspect of the present invention relates to an apparatus for the efficient synthesis of oligosaccharides on a solid support, e.g., formed by subunit addition to terminal subunits immobilized on solid-phase particles. In certain embodiments, the apparatus of the present invention is used in combinatorial methods, e.g., as described herein, of synthesizing oligosaccharides.

    专利号:US-6794534-B2
    优先权日:2000-06-23
    标题:Synthesis of functionalized and unfunctionalized olefins via cross and ring-closing metathesis
    发明人:GRUBBS ROBERT H; CHATTERJEE ARNAB K; MORGAN JOHN P; SCHOLL MATTHIAS; CHOI TAE-LIM
    权利人:CALIFORNIA INST OF TECHN
    摘要:The invention is directed to the cross-metathesis and ring-closing metathesis reactions between geminal disubstituted olefins and terminal olefins, wherein the reaction employs a Ruthenium or Osmium metal carbene complex. Specifically, the invention relates to the synthesis of α-functionalized or unfunctionalized olefins via intermolecular cross-metathesis and intramolecular ring-closing metathesis using a ruthenium alkylidene complex. The catalysts preferably used in the invention are of the general formula n wherein: n M is ruthenium or osmium; n X and X 1 are each independently an anionic ligand; n L is a neutral electron donor ligand; and, n R, R 1 R 6 , R 7 , R 8 , and R 9 are each independently hydrogen or a substituent selected from the group consisting of C 1 -C 20 alkyl, C 2 -C 20 alkenyl, C 2 -C 20 alkynyl, aryl, C 1 -C 20 carboxylate, C 1 -C 20 alkoxy, C 2 -C 20 alkenyloxy, C 2 -C 20 alkynyloxy, aryloxy, C 2 -C 20 alkoxycarbonyl, C 1 -C 20 alkylthio, C 1 -C 20 alkylsulfonyl and C 1 -C 20 alkylsulfinyl.

    专利号:US-8822702-B2
    优先权日:2002-12-20
    标 题 :Synthesis of amines and intermediates for the synthesis thereof
    发明人:BERENS ULRICH; DOSENBACH OLIVER; SPRENGER DANIEL
    权利人:BERENS ULRICH; DOSENBACH OLIVER; SPRENGER DANIEL; BASF SE
    摘要:The invention relates in a first embodiment to a method for the manufacture of esters of the formula I, n nor especially of amides of the formula II,n n nwherein the symbols have the meanings given in the specification, as well as other intermediates and compounds useful in the synthesis of tryptamines and other substances mentioned in the title. The synthesis methods and intermediates are useful in the synthesis of pharmaceuticals.

    专利号:US-5936080-A
    优先权日:1996-05-24
    标题 :Compositions and methods for the synthesis of organophosphorus derivatives
    发明人:STEC WOJCIECH J; WOZNIAK LUCYNA
    权利人:GENTA INC; POLSKA AKADEMIA NAUK INSTYTUT
    摘要:New organophosphorus mononucleoside derivatives, methods of their synthesis and methods for the synthesis of organophosphorus dinucleotide derivatives utilizing the organophosphorus mononucleosides are provided. Synthesized organophosphorus mononucleoside derivatives of the present invention are characterized by the formula; ##STR1## Organophosphorus dinucleoside derivatives prepared from the synthesis methods provided in the present invention are characterized by the formula; ##STR2##

    专利号:US-2024287520-A1
    优先权日:2021-06-30
    标题:Method for synthesis of linkage modified oligomeric compounds
    发明人:RODRIGUEZ ANDREW A
    权利人:IONIS PHARMACEUTICALS INC
    摘要:The present disclosure provides methods of synthesizing modified oligonucletodies and oligomeric compounds (including oligomeric compounds that are antisense agents or portions thereof) comprising a modified oligonucleotide having at least one modified internucleoside linking group. In certain embodiments, the present disclosure provides stabilized formulations of certain sulfonyl azides for use in the synthesis of olignonucleotides comprising one or more sulfonyl phosphoramidate linkages. Some embodiments provide stabilized compositions of high energy reagents that may be used in the synthesis of modified oligonucleotides, allowing for safe process scale preparation thereof.

    专利号:US-2016031800-A1
    优先权日:2013-03-14
    标 题:Synthesis of chiral kynurenine compounds and intermediates
    发明人:TRETYAKOV ALEXANDER; DROUET KEITH E; SANDERS WILLIAM
    权利人:VISTAGEN THERAPEUTICS INC
    摘要:Provided are methods for the synthesis of compounds including chiral kynurenine compounds, intermediates useful for the synthesis thereof, and related compounds. For example, methods are provided for the synthesis of L-4-chlorokynurenine.
    常熟市联创化学有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.leaguechemical.com
    企业联系电话:0512-52546388;13915608587👤
    📞常熟市联创化学有限公司 ⚠️参考联系方式
    联系人:陈龙
    电话:0512-52546388;13915608587
    手机:13915608587
    传真:0512-52540118
    邮箱:league@league-chem.com
    通信地址: 江苏省常熟市何市镇
    邮编: 215538
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江苏省常熟市何市镇
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    常州联润生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.uniringchem.com
    企业联系电话:0519-81886306,18006116801👤
    📞常州联润生物科技有限公司 ⚠️参考联系方式
    联系人:缪先生
    电话:0519-81886306,18006116801
    手机:18006116801
    传真:0519-81886306
    邮箱:sales@uniringchem.com
    通信地址: 常州罗溪镇塑化路25号
    邮编: 213000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:常州罗溪镇塑化路25号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    参考标题:Sequential 1,3-N- To C- And 1,3-C- To C-Migration Of Sulfonyl Groups Through The Synthesis Of 1,4-Diazepines From The Aza-[5 + 2] Cycloaddition Of Indoloazomethine Ylides
    作者:Namrim Heo,Ilyong Jung,Dae Kyum Kim,Sang Hoon Han,Kooyeon Lee,Phil Ho Lee |发布日期:2020.8.21
    摘要:Sequential 1,3-N- To C- And 1,3-C- To C-Migration Of Sulfonyl Groups Through The Synthesis Of 1,4-Diazepines From An Operationally Simple Thermal Aza-[5 + 2] Cycloaddition Reaction Of Indoloazomethine Ylides With Dialkyl Acetylenedicarboxylates Under Mild Conditions, Leading To The Formation Of C-Sulfonylated 1,4-Diazepines.

    合成参考文献


    参考文献:10.1021/jm200536d
    摘要:Andrés JI, De Angelis M, Alcázar J, Iturrino L, Langlois X, Dedeurwaerdere S, Lenaerts I, Vanhoof G, Celen S, Bormans G. Synthesis, in vivo occupancy, and radiolabeling of potent phosphodiesterase subtype-10 inhibitors as candidates for positron emission tomography imaging. J Med Chem. 2011 Aug 25;54(16):5820–35. doi: 10.1021/jm200536d.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知